General Information of the Compound
| Compound ID |
CP0500463
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(8S,11R,13S,14S,17S)-13-methyl-3-oxo-17-prop-1-ynyl-11-[2-(trifluoromethyl)-1,3-benzoxazol-5-yl]-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]formamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H29F3N2O3
|
||||||||||||||||||
| Molecular Weight |
522.567
|
||||||||||||||||||
| Canonical SMILES |
CC#C[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c1ccc2oc(nc2c1)C(F)(F)F)NC=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H29F3N2O3/c1-3-11-29(34-16-36)12-10-23-21-7-4-17-13-19(37)6-8-20(17)26(21)22(15-28(23,29)2)18-5-9-25-24(14-18)35-27(38-25)30(31,32)33/h5,9,13-14,16,21-23H,4,6-8,10,12,15H2,1-2H3,(H,34,36)/t21-,22+,23-,28-,29-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WSGANSMSRKUENH-UFWDGWHQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00967, Glucocorticoid receptor
Protein ID: PT01172, Progesterone receptor